rs730881184

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_014795.4(ZEB2):​c.139G>T​(p.Ala47Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000041 in 1,461,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A47A) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

ZEB2
NM_014795.4 missense

Scores

6
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 5.79

Publications

0 publications found
Variant links:
Genes affected
ZEB2 (HGNC:14881): (zinc finger E-box binding homeobox 2) The protein encoded by this gene is a member of the Zfh1 family of 2-handed zinc finger/homeodomain proteins. It is located in the nucleus and functions as a DNA-binding transcriptional repressor that interacts with activated SMADs. Mutations in this gene are associated with Hirschsprung disease/Mowat-Wilson syndrome. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jan 2010]
ZEB2 Gene-Disease associations (from GenCC):
  • Mowat-Wilson syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21674573).
BP6
Variant 2-144429961-C-A is Benign according to our data. Variant chr2-144429961-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 181722.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZEB2NM_014795.4 linkc.139G>T p.Ala47Ser missense_variant Exon 3 of 10 ENST00000627532.3 NP_055610.1 O60315-1
ZEB2NM_001171653.2 linkc.139G>T p.Ala47Ser missense_variant Exon 3 of 9 NP_001165124.1 O60315-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZEB2ENST00000627532.3 linkc.139G>T p.Ala47Ser missense_variant Exon 3 of 10 1 NM_014795.4 ENSP00000487174.1 O60315-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000120
AC:
3
AN:
251016
AF XY:
0.00000737
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000869
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000410
AC:
6
AN:
1461634
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33456
American (AMR)
AF:
0.000134
AC:
6
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111868
Other (OTH)
AF:
0.00
AC:
0
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.533
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000491
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mowat-Wilson syndrome Benign:2
Nov 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 14, 2014
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Inborn genetic diseases Benign:1
Feb 06, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.060
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
20
DANN
Benign
0.91
DEOGEN2
Benign
0.0027
T;T;T;T;T;.;T;T;T;T;.;T;.;T;T;.;T
Eigen
Uncertain
0.29
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.88
D;.;D;.;D;D;D;D;D;D;D;D;T;D;D;D;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.22
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-0.18
.;N;.;N;.;N;N;.;.;.;.;.;.;.;.;.;.
PhyloP100
5.8
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.20
.;.;.;N;.;N;N;N;.;.;.;.;.;N;.;N;N
REVEL
Uncertain
0.37
Sift
Benign
0.50
.;.;.;T;.;T;T;T;.;.;.;.;.;T;.;T;T
Sift4G
Benign
0.85
.;T;T;T;.;T;T;T;T;.;.;T;.;T;.;.;T
Polyphen
0.0090
.;B;.;B;.;.;B;B;.;.;.;.;.;.;.;.;.
Vest4
0.32, 0.31, 0.40, 0.27, 0.29, 0.32, 0.28
MutPred
0.27
Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);.;.;Gain of phosphorylation at A47 (P = 0.021);.;Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);Gain of phosphorylation at A47 (P = 0.021);
MVP
0.56
MPC
0.65
ClinPred
0.13
T
GERP RS
5.9
Varity_R
0.069
gMVP
0.089
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs730881184; hg19: chr2-145187528; API